{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:19:16Z","timestamp":1791011956581,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1136\/ard.2010.131326","type":"journal-article","created":{"date-parts":[[2010,6,26]],"date-time":"2010-06-26T00:31:25Z","timestamp":1277512285000},"page":"2181-2188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["B-cell-activating factor receptor expression on naive and memory B cells: relationship with relapse in patients with rheumatoid arthritis following B-cell depletion therapy"],"prefix":"10.1016","volume":"69","author":[{"given":"Inmaculada","family":"de la Torre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita A","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J","family":"Leandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Cambridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2010.131326_bib1","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","article-title":"Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations","volume":"190","author":"Mackay","year":"1999","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2010.131326_bib2","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.4049\/jimmunol.173.4.2331","article-title":"B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation","volume":"173","author":"Shulga-Morskaya","year":"2004","journal-title":"J Immunol"},{"key":"10.1136\/ard.2010.131326_bib3","doi-asserted-by":"crossref","first-page":"7729","DOI":"10.4049\/jimmunol.0803281","article-title":"B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2","volume":"182","author":"Castro","year":"2009","journal-title":"J Immunol"},{"key":"10.1136\/ard.2010.131326_bib4","first-page":"3872","article-title":"Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease","volume":"179","author":"Enzler","year":"2007","journal-title":"J Immunol"},{"key":"10.1136\/ard.2010.131326_bib5","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.4049\/jimmunol.173.4.2245","article-title":"TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology","volume":"173","author":"Sasaki","year":"2004","journal-title":"J Immunol"},{"key":"10.1136\/ard.2010.131326_bib6","doi-asserted-by":"crossref","first-page":"13945","DOI":"10.1073\/pnas.0903543106","article-title":"B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans","volume":"106","author":"Warnatz","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2010.131326_bib7","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.4049\/jimmunol.179.11.7276","article-title":"Regulated expression of BAFF-binding receptors during human B cell differentiation","volume":"179","author":"Darce","year":"2007","journal-title":"J Immunol"},{"key":"10.1136\/ard.2010.131326_bib8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nri2572","article-title":"Cracking the BAFF code","volume":"9","author":"Mackay","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1136\/ard.2010.131326_bib9","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1136\/ard.2008.095257","article-title":"Quantitative assessment of antibodies to ribonucleoproteins in primary Sj\u00f6gren syndrome: correlation with B-cell biomarkers and disease activity","volume":"68","author":"Candon","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.131326_bib10","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1002\/art.11354","article-title":"B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations","volume":"48","author":"Stohl","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.131326_bib11","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S","article-title":"Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases","volume":"44","author":"Cheema","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.131326_bib12","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/ard.2007.079418","article-title":"B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response","volume":"67","author":"Cambridge","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.131326_bib13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1177\/0961203306071871","article-title":"B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time","volume":"15","author":"Becker-Merok","year":"2006","journal-title":"Lupus"},{"key":"10.1136\/ard.2010.131326_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1313.004","article-title":"BAFF overexpression is associated with autoantibody production in autoimmune diseases","volume":"1050","author":"Pers","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1136\/ard.2010.131326_bib15","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1182\/blood-2009-05-217513","article-title":"The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia","volume":"114","author":"Zhu","year":"2009","journal-title":"Blood"},{"key":"10.1136\/ard.2010.131326_bib16","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/ar2773","article-title":"Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort","volume":"11","author":"Gottenberg","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2010.131326_bib17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/art.21650","article-title":"Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse","volume":"54","author":"Cambridge","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.131326_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2249.2009.03978.x","article-title":"Translational Mini-Review Series on B Cell-Directed Therapies: the pathogenic role of B cells in autoantibody-associated autoimmune diseases \u2013 lessons from B cell-depletion therapy","volume":"157","author":"Leandro","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2010.131326_bib19","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/ard.2006.065656","article-title":"Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sj\u00f6gren's syndrome and systemic lupus erythematosus","volume":"66","author":"Sellam","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.131326_bib20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/art.21617","article-title":"Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis","volume":"54","author":"Leandro","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.131326_bib21","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/art.11181","article-title":"Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis","volume":"48","author":"Cambridge","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.131326_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.131326_bib23","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/art.23473","article-title":"Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment","volume":"58","author":"Roll","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.131326_bib24","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1002\/art.24035","article-title":"Disease activity-guided rituximab therapy in rheumatoid arthritis: the effects of re-treatment in initial nonresponders versus initial responders","volume":"58","author":"Thurlings","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.131326_bib25","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1002\/art.21489","article-title":"Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus","volume":"52","author":"Carter","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.131326_bib26","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/art.22019","article-title":"Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis","volume":"54","author":"Roll","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"Suppl 3","key":"10.1136\/ard.2010.131326_bib27","doi-asserted-by":"crossref","first-page":"iii34","DOI":"10.1136\/ard.2006.058412","article-title":"The BLyS\/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity","volume":"65","author":"Cancro","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.131326_bib28","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.4049\/jimmunol.179.11.7276","article-title":"Divergent effects of BAFF on human memory B cell differentiation into Ig-secreting cells","volume":"179","author":"Darce","year":"2007","journal-title":"J Immunol"},{"key":"10.1136\/ard.2010.131326_bib29","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.4049\/jimmunol.0713370","article-title":"Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling","volume":"182","author":"Arechiga","year":"2009","journal-title":"J Immunol"},{"key":"10.1136\/ard.2010.131326_bib30","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1084\/jem.20082392","article-title":"Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity","volume":"206","author":"Kubo","year":"2009","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2010.131326_bib31","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1084\/jem.20042321","article-title":"Impaired early B cell tolerance in patients with rheumatoid arthritis","volume":"201","author":"Samuels","year":"2005","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2010.131326_bib32","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/eji.200838617","article-title":"Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients","volume":"39","author":"Rudnicka","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1136\/ard.2010.131326_bib33","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.exphem.2006.05.013","article-title":"Developmental stage-specific shift in responsiveness to chemokines during human B-cell development","volume":"34","author":"Honczarenko","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1136\/ard.2010.131326_bib34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1084\/jem.173.2.487","article-title":"Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells","volume":"173","author":"Roosnek","year":"1991","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2010.131326_bib35","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/ard.2008.092791","article-title":"Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation","volume":"68","author":"Teng","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.131326_bib36","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/ar2798","article-title":"Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response","volume":"11","author":"Nakou","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2010.131326_bib37","doi-asserted-by":"crossref","first-page":"R62","DOI":"10.1186\/ar2686","article-title":"Class-switched B cells display response to therapeutic B-cell depletion in rheumatoid arthritis","volume":"11","author":"M\u00f6ller","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2010.131326_bib38","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.4049\/jimmunol.178.10.6624","article-title":"A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus","volume":"178","author":"Wei","year":"2007","journal-title":"J Immunol"},{"key":"10.1136\/ard.2010.131326_bib39","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/art.23498","article-title":"Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95","volume":"58","author":"Jacobi","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.131326_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.0105-2896.2004.0109.x","article-title":"Peripheral development of B cells in mouse and man","volume":"197","author":"Carsetti","year":"2004","journal-title":"Immunol Rev"}],"updated-by":[{"DOI":"10.1136\/ard.2010.131326corr1","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000}}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724147723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724147723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2010.131326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T23:59:28Z","timestamp":1737244768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724147723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0003496724147723"],"URL":"https:\/\/doi.org\/10.1136\/ard.2010.131326","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B-cell-activating factor receptor expression on naive and memory B cells: relationship with relapse in patients with rheumatoid arthritis following B-cell depletion therapy","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2010.131326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}